SA
ALM.D

Nasdaq, Russell 2000 below the 200-day average · S&P 500 below the 50-day average (VIX 22.8)

Overview →

ALM.D News

About

Almirall S.A. Right represents a type of derivative security issued in connection with Almirall S.A., a global biopharmaceutical company headquartered in Barcelona. As a right, this financial instrument typically grants shareholders a time-limited privilege to purchase additional ordinary shares of Almirall S.A., often at a set price and in proportion to their existing holdings. These rights are commonly distributed during capital-raising events, such as rights issues, enabling the company to attract fresh equity capital while offering current shareholders the opportunity to maintain or increase their ownership percentage. Almirall S.A. is recognized for its focus on medical dermatology and skin health, with a broad presence across Europe, the United States, and other markets. The issuance of rights by Almirall S.A. underscores its active approach to capital management and shareholder engagement, serving as an important mechanism for financing strategic growth or research initiatives within the pharmaceutical sector.

Country
Spain
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.